1.Health risk assessment of heavy metals and metalloids in atmospheric PM2.5 from Inner Mongolia Autonomous Region in 2023
Jiake ZHU ; Shengmei YANG ; Yuhan QIN ; Nana WEI ; Wenqian ZHANG ; Xinrui JIA ; Wenyu ZHANG ; Xuanhao BAI ; Minghui YIN ; Li ZHANG ; Huan LI ; Duoduo WU ; Xuanzhi YUE ; Yaochun FAN
Journal of Environmental and Occupational Medicine 2025;42(10):1201-1208
Background The Inner Mongolia Autonomous Region is a vast area with a wide array of ecological environments, resulting in considerable regional variations in air pollution characteristics. Current research is limited by a scarcity of systematic, region-wide studies and risk assessments. Objective To assess the health risks associated with inhalation exposure to nine heavy metal and metalloid elements in atmospheric fine particulate matter (PM2.5) for the population of the Inner Mongolia Autonomous Region. Methods From the 10th to the 16th of each month throughout 2023, atmospheric PM2.5 samples were collected at designated monitoring sites in 12 leagues (cities) across the Inner Mongolia Autonomous Region to analyze the characteristics and trends in concentration. The health risk assessment model developed by the United States Environmental Protection Agency was employed to evaluate both the non-carcinogenic and carcinogenic risks associated with the heavy metal elements beryllium (Be), cadmium (Cd), chromium (Cr), hydrargyrum (Hg), plumbum (Pb), manganese (Mn), and nickel (Ni) and the metalloid elements stibium (Sb) and arsenic (As). Results In 2023, a total of
2.Research progress of gut microbiota in the prevention and treatment of colorectal cancer
Ping LAN ; Shengmei YIN ; Zhen HE
Chinese Journal of Digestive Surgery 2022;21(6):730-736
Colorectal cancer is a common malignancy of the digestive tract, and the gut microbiota is closely related to the occurrence and development of colorectal cancer. The intestinal florae mainly change the host intestinal immune environment and affect the function of the intes-tinal barrier by releasing toxins and producing metabolites to participate the occurrence and deve-lopment of colon cancer. The intestinal florae can be used as biomarkers for early screening and prognosis prediction for colorectal cancer. In addition, the intestinal florae can affect the efficacy of chemotherapy, radiotherapy and immunotherapy for colorectal cancer. The authors review the research progress of gut microbiota in occurrence and development, screening, prognosis prediction and treatment of colorectal cancer, and discuss the application prospects of gut microbiota in the prevention and treatment of colorectal cancer.

Result Analysis
Print
Save
E-mail